Recombinant Human DICER1, N-His

Introduction to Recombinant Human DICER1

Recombinant Human DICER1 is a protein that plays a crucial role in the process of RNA interference (RNAi). This protein is produced through recombinant DNA technology, where the gene for human DICER1 is inserted into a host organism, typically a bacterial or mammalian cell, to produce large quantities of the protein. Recombinant Human DICER1 has been extensively studied and has shown promising potential in various fields, including cancer research, gene therapy, and drug development.

Structure of Recombinant Human DICER1

Recombinant Human DICER1 is a large protein with a molecular weight of approximately 220 kDa. It is composed of two RNase III domains, a PAZ domain, and a helicase domain. The RNase III domains are responsible for cleaving double-stranded RNA molecules, while the PAZ domain binds to the end of the RNA strand. The helicase domain, on the other hand, unwinds the double-stranded RNA, allowing for the cleavage by the RNase III domains. This unique structure of Recombinant Human DICER1 enables it to efficiently process RNA molecules and play a crucial role in the RNAi pathway.

Activity of Recombinant Human DICER1

The main function of Recombinant Human DICER1 is to process double-stranded RNA molecules into short interfering RNA (siRNA) molecules. This process is known as RNA interference (RNAi) and is a natural mechanism used by cells to regulate gene expression. Recombinant Human DICER1 is able to recognize and cleave the double-stranded RNA molecules at specific sites, producing siRNA molecules that are approximately 21-23 nucleotides in length. These siRNA molecules then bind to the RNA-induced silencing complex (RISC) and guide it to target mRNA molecules, leading to their degradation and silencing of gene expression.

In addition to its role in RNAi, Recombinant Human DICER1 has also been found to have other activities. It has been shown to play a role in DNA damage response, where it is involved in the repair of double-stranded DNA breaks. It has also been implicated in the regulation of gene expression at the transcriptional level, as well as in the processing of viral RNA during viral infections.

Applications of Recombinant Human DICER1

Recombinant Human DICER1 has numerous potential applications in the fields of medicine and biotechnology. One of its most promising applications is in cancer research, where it has been shown to play a role in tumor suppression. Studies have found that mutations in the DICER1 gene are associated with certain types of cancer, such as ovarian, lung, and thyroid cancer. Recombinant Human DICER1 has also been used in gene therapy, where it is used to silence specific genes that are responsible for disease development.

Another potential application of Recombinant Human DICER1 is in drug development. By understanding the structure and activity of this protein, researchers can develop drugs that target specific steps in the RNAi pathway, which could potentially lead to the development of new treatments for diseases such as cancer, viral infections, and genetic disorders.

Conclusion

In summary, Recombinant Human DICER1 is a crucial protein involved in the RNAi pathway. Its unique structure and activity make it a valuable tool in various fields, including cancer research, gene therapy, and drug development. With further research and understanding of this protein, it has the potential to revolutionize the way we treat diseases and improve human health.